(Q39740912)

14 September 2017

An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative (English)

1 reference

Alzheimer's Disease Neuroimaging Initiative

14 September 2017

0 references

0 references

0 references

8

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

14 September 2017

Mahesh N Samtani

1

1 reference

14 September 2017

Michael Farnum

2

1 reference

14 September 2017

Victor Lobanov

3

1 reference

14 September 2017

Eric Yang

4

1 reference

14 September 2017

Nandini Raghavan

5

1 reference

14 September 2017

Allitia Dibernardo

6

1 reference

14 September 2017

Vaibhav Narayan

7

1 reference

14 September 2017

9 June 2011

1 reference

The Journal of Clinical Pharmacology

14 September 2017

1 reference

14 September 2017

52

1 reference

14 September 2017

5

1 reference

14 September 2017

629-644

1 reference

Assessing change in cognitive function in dementia: the relative utilities of the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Cognitive Drug Research system

14 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Disease progression meta-analysis model in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Modeling the time-course of Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Analysis of logistic growth models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

The effect of collinearity on parameter estimates in nonlinear mixed effect models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

The Alzheimer's Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer's disease trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

PsN-Toolkit--a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Comparison of stepwise covariate model building strategies in population pharmacokinetic-pharmacodynamic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Diversity of mechanism-based pharmacodynamic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

A systematic review of assessment and treatment of moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Apolipoprotein E4 allele and Alzheimer disease: examination of allelic association and effect on age at onset in both early- and late-onset cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Apolipoprotein E polymorphism and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Statins for the treatment of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Hippocampal atrophy in Alzheimer disease: age matters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Serial MRI and CSF biomarkers in normal aging, MCI, and AD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270011405497

21 January 2018

Identifiers

DOI

10.1177/0091270011405497

1 reference

14 September 2017

1 reference